|
iBiopharm
Co., Ltd.
was established
as a PK/Bioanalytical
CRO to contribute
to drug developments
in Korea and world
wide. Over the past
years, iBiopharm
has developed significant
global standards
in our services
and is watching
the continuous growth
of expertise.
iBiopharm
is the first CRO
that acquired GLP
certificate in the
field of toxicokinetic
analysis by Korea
Food and Drug Administration
(KFDA). iBiopharm
also provides bioanalytical
services with the
international standard
(ICH guidelines).
Our service is available
to domestic and
abroad clients.
We devoted ourselves
to provide customized,
up-to-date technologies
and services to
meet the demands
of our clients with
regard to cost,
speed, and quality
of data. Also, we
maintain technical
collaboration with
outstanding domestic
and foreign research
institutes.
iBiopharmĄ¯s
goal is to
consistently provide
our customers with
the best quality
of data maintaining
full compliance
with the regulatory
requirements. Through
continuous education
and training of
our staffs with
the help of state-of-the-art
equipments, iBiopharm
is directing its
best efforts to
achieve this goal.
|
